Construction of [ 89 Zr]Zr-Labeled HuL13 for ImmunoPET Imaging of LAG-3 Checkpoint Expression on Tumor-Infiltrating T Cells
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Lixin Ding und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Resea…. Hauptthemen laut MEDLINE: Lymphocyte Activation Gene 3 Protein, Zirconium, Lymphocytes, Tumor-Infiltrating, Positron-Emission Tomography. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Beijing Municipal Health Commission, Organization Department of the Central Committee of the Communist Party of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Lymphocyte activation gene 3 (LAG-3) has attracted much attention as a potentially valuable immune checkpoint. Individual identification of LAG-3 expression at screening and during treatment could improve the successful implementation of anti-LAG-3 therapies. HuL13 is a human IgG1 monoclonal antibody that binds to the LAG-3 receptor in T cells. Here, we used [89Zr]Zr-labeled HuL13 to delineate LAG-3+ T-cell infiltration into tumors via positron emission tomography (PET) imaging. A549/LAG-3 cells, which stably express LAG-3, were generated by infection with lentivirus. The uptake of [89Zr]Zr-DFO-HuL13 in A549/LAG-3 cells was greater than that in the negative control (A549/NC) cells at each time point. The equilibrium dissociation constant (Kd) of [89Zr]Zr-DFO-HuL13 for the LAG-3 receptor was 8.22 nM. PET imaging revealed significant uptake in the tumor areas of A549/LAG-3 tumor-bearing mice from 24 h after injection (SUVmax = 2.43 ± 0.06 at 24 h). As a proof of concept, PET imaging of the [89Zr]Zr-DFO-HuL13 tracer was further investigated in an MC38 tumor-bearing humanized LAG-3 mouse model. PET imaging revealed that the [89Zr]Zr-DFO-HuL13 tracer specifically targets human LAG-3 expressed on tumor-infiltrating lymphocytes (TILs). In addition to the tumors, the spleen was also noticeably visible. Tumor uptake of the [89Zr]Zr-DFO-HuL13 tracer was lower than its uptake in the spleen, but high uptake in the spleen could be reduced by coinjection of unlabeled antibodies. Coinjection of unlabeled antibodies increases tracer activity in the blood pool, thereby improving tumor uptake. Dosimetry evaluation of the healthy mouse models revealed that the highest absorbed radiation dose was in the spleen, followed by the liver and heart wall. In summary, these studies demonstrate the feasibility of using the [89Zr]Zr-DFO-HuL13 tracer for the detection of LAG-3 expression on TILs. Further clinical evaluation of the [89Zr]Zr-DFO-HuL13 tracer may be of significant help in the stratification and management of patients suitable for anti-LAG-3 therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceu…
- Hefei HankeMab Biotechnology Limited, Hefei, Anhui 230088, China.
- Office for Public Health Management, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Förderung
- Beijing Municipal Health Commission
- Organization Department of the Central Committee of the Communist Party of China
- National Natural Science Foundation of China
Zitieren
APA
Ding, L., Wang, F., Wang, Z., Pan, Y., Liu, T., Cheng, L., Liu, W., Ding, K., Zhu, H., & Yang, Z. (2024). Construction of [ 89 Zr]Zr-Labeled HuL13 for ImmunoPET Imaging of LAG-3 Checkpoint Expression on Tumor-Infiltrating T Cells. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00343
Vancouver
Ding L, Wang F, Wang Z, Pan Y, Liu T, Cheng L, et al. Construction of [ 89 Zr]Zr-Labeled HuL13 for ImmunoPET Imaging of LAG-3 Checkpoint Expression on Tumor-Infiltrating T Cells. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00343
BibTeX
@article{Ding2024,
author = {Ding, Lixin and Wang, Feng and Wang, Zilei and Pan, Yongxiang and Liu, Teli and Cheng, Liansheng and Liu, Wenting and Ding, Kuke and Zhu, Hua and Yang, Zhi},
title = {Construction of [ 89 Zr]Zr-Labeled HuL13 for ImmunoPET Imaging of LAG-3 Checkpoint Expression on Tumor-Infiltrating T Cells},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00343}
}
EUVIMED